Clinical Trials Directory

Trials / Completed

CompletedNCT01694095

Evolution and Risk Factors Associated With Geographic Atrophy Progression

Characterization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration

Status
Completed
Phase
Study type
Observational
Enrollment
96 (actual)
Sponsor
Institut de la Macula y la Retina · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Age-related macular degeneration is one of the leading causes of blindness worldwide. The factors that induce the progression of geographic atrophy, the advanced form of dry age-related macular degeneration, remain poorly understood. The aims of this study are to describe the natural history of geographic atrophy and identify potential risk factors associated with a faster spread of atrophy that may be used to develop rational therapies.

Detailed description

Age-related macular degeneration is the leading cause of blindness in developed countries. Geographic atrophy is the advanced form of dry age-related macular degeneration, and currently has no effective therapy. Little is known about the risk factors that drive the progression of geographic atrophy, and yet they are crucial to understand the mechanisms of the disease. Therefore, the identification of risk factors associated with a faster spread of atrophy may help contribute to identify the causes of the disease and, ultimately, to develop new therapeutic strategies to manage the disorder. The current prospective, observational, natural history study has the following objectives: * Describe the natural history of geographic atrophy in anatomic and visual terms * Identify risk factors associated with a faster enlargement of atrophy The main hypothesis is that lipofuscin accumulation at the borders of atrophy as seen with fundus autofluorescence imaging is associated with a faster progression of the disease.

Conditions

Timeline

Start date
2009-12-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2012-09-26
Last updated
2015-03-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01694095. Inclusion in this directory is not an endorsement.